Capecitabine

Celabin™

Prescription Drug

Indication

Capecitabine is indicated for the following conditions:

Colorectal Cancer

• Adjuvant treatment of patients following surgery of stage III (Dukes’ stage C) colon cancer when treatment with fluoropyrimidine therapy alone is preferred.
• First-line treatment of metastatic colorectal cancer when treatment with fluoropyrimidine therapy alone is preferred.
• Treatment, in combination with oxaliplatin, of patients with metastatic colorectal cancer following failure of irinotecan-containing combination chemotherapy.

Breast Cancer

• Treatment, in combination with docetaxel, of patients with locally advanced or metastatic breast cancer after failure of prior anthracyline-containing chemotherapy.
• Treatment, as monotherapy, of patients with locally advanced or metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen or resistant to paclitaxel and for whom further anthracycline therapy is not indicated.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.